Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-30 08:30 am Unchanged | 13D | TECHPRECISION CORP TPCS | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 433,605 4.800% | 0 (Unchanged) | View |
| 2024-07-05 2:17 pm Unchanged | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 5,007,666 16.000% | 0 (Unchanged) | View |
| 2024-07-02 4:54 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 5,007,666 16.000% | 80,871 (+1.64%) | View |
| 2024-07-02 4:32 pm Purchase | 13D | TECHPRECISION CORP TPCS | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 433,605 4.800% | 433,605 (New Position) | View |
| 2023-03-16 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,926,795 16.600% | 464,285 (+10.40%) | View |
| 2023-02-16 4:43 pm Purchase | 13G | S&W Seed Co SANW | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,112,950 9.700% | 4,112,950 (New Position) | View |
| 2022-12-02 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,462,510 14.800% | 884,805 (+24.73%) | View |
| 2022-03-22 4:15 pm Sale | 13D | Summer Infant Inc. SUMR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 784,183 36.200% | -6,044,903 (-88.52%) | View |
| 2022-01-20 4:16 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,577,705 12.100% | 387,400 (+12.14%) | View |
| 2021-04-20 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,190,305 10.900% | 507,905 (+18.93%) | View |
| 2020-11-03 4:23 pm Purchase | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,111,874 6.400% | 100,000 (+4.97%) | View |
| 2020-10-28 3:57 pm Sale | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,874 6.100% | -31 (-0.00%) | View |
| 2020-08-14 5:14 pm Purchase | 13D | MVC CAPITAL INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,559,270 8.800% | 44,891 (+2.96%) | View |
| 2020-07-13 2:07 pm Purchase | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,905 6.200% | 80,600 (+4.17%) | View |
| 2020-06-01 4:30 pm Unchanged | 13D | MVC CAPITAL INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.500% | 0 (Unchanged) | View |
| 2020-04-27 4:47 pm Unchanged | 13D | MVC CAPITAL INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.500% | 0 (Unchanged) | View |
| 2020-04-21 5:02 pm Unchanged | 13D | MVC CAPITAL INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.500% | 0 (Unchanged) | View |
| 2020-01-22 4:19 pm Sale | 13D | MVC CAPITAL INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.500% | -85,621 (-5.35%) | View |